SCHEMBL17540919

SCHEMBL17540919

CC(S)C(=O)OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
TDP1 Q9NUW8 2/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A3 Q01959 1/20 0.53
KMT2A Q03164 1/20 0.53
LMNA P02545 2/20 0.49
HCAR2 Q8TDS4 1/20 0.49
ATM Q13315 1/20 0.48
CTRB1 P17538 2/20 0.47
CTSB P07858 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
ELANE P08246 1/20 0.46
CTSK P43235 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1200519 0.85 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL12640200 0.84 ALDH1A1 (0.64) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL939536 0.84 ALDH1A1 (0.64) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL112859 0.84 ALDH1A1 (0.64) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL162538 0.84 ALDH1A1 (0.59) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL12746764 0.84 ALDH1A1 (0.55) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL201855 0.82 ALDH1A1 (0.62) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL9248648 0.82 ALDH1A1 (0.62) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
Hydrochloric Acid SCHEMBL29090140 0.82 ALDH1A1 (0.62) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL1107604 0.82 ALDH1A1 (0.62) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119960255-A Photosensitive resin composition, resist ink, resist laminate and use thereof 杭州福斯特电子材料有限公司 2025-05-09 CN claimed
CN-119960255-A Photosensitive resin composition, resist ink, resist laminate and use thereof 杭州福斯特电子材料有限公司 2025-05-09 CN disclosed
EP-3527597-B1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, AND USE THEREOF MITSUI CHEMICALS INC (JP) 2024-08-07 EP disclosed
US-11911751-B2 Catalyst compositions for hydroformylation and methods of use thereof BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-02-27 US disclosed
CN-113900355-B Photosensitive resin composition and dry film resist laminate 杭州福斯特电子材料有限公司 2024-01-30 CN disclosed
US-20230142139-A1 CATALYST COMPOSITIONS FOR HYDROFORMYLATION AND METHODS OF USE THEREOF BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2023-05-11 US disclosed
CN-116088271-A Photosensitive resin composition and dry film resist laminate 杭州福斯特电子材料有限公司 2023-05-09 CN disclosed
US-11639413-B2 Polymerizable composition for optical materials and application of same MITSUI CHEMICALS, INC. (JP) 2023-05-02 US disclosed
US-11498923-B2 Substituted imidazo[1,2-c]quinazolines as A2A antagonists MERCK SHARP & DOHME LLC (US) 2022-11-15 US disclosed
CN-115047714-A Resist composition and laminate thereof 杭州福斯特电子材料有限公司 2022-09-13 CN disclosed
CN-114355728-A Dry film resist laminated body and preparation method and application thereof 杭州福斯特电子材料有限公司 2022-04-15 CN disclosed
US-20210053973-A1 IMIDAZO[1,2-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES MERCK SHARP & DOHME CORP. (US) 2021-02-25 US disclosed
EP-3186226-B1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2020-06-17 EP disclosed
EP-3099691-B1 PRO-SUBSTRATES FOR LIVE CELL APPLICATIONS PROMEGA CORP (US) 2019-11-20 EP disclosed
US-20190284324-A1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIALS AND APPLICATION OF SAME MITSUI CHEMICALS, INC. (JP) 2019-09-19 US disclosed
EP-3527597-A1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2019-08-21 EP disclosed
US-20170260132-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2017-09-14 US disclosed
EP-3186226-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2017-07-05 EP disclosed
WO-2016030790-A1 OXIME SULFONATE DERIVATIVES BASF SE (DE) 2016-03-03 WO disclosed
US-9029407-B2 Aminothiazole modulators of beta-3-adrenoreceptor AUSPEX PHARMACEUTICALS, INC. (US) 2015-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260132-A1 OXIME SULFONATE DERIVATIVES CBR3, CBR1, C1R ALDH1A1 1495/4885TDP1 3750/4885MAPK1 2103/4885
US-11498923-B2 Substituted imidazo[1,2-c]quinazolines as A2A antagonists ADORA2A, ADORA3, ADORA1 ALDH1A1 995/4885TDP1 1173/4885MAPK1 1199/4885
US-20210053973-A1 IMIDAZO[1,2-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES ADORA2A, ADORA3, ADORA1 ALDH1A1 969/4885TDP1 1038/4885MAPK1 1355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.